We are excited to announce that Axial3D has successfully secured $18.2 million in funding to enhance our mission of revolutionizing the healthcare landscape through medical segmentation and 3D printing. As a pioneering company in this field, Axial3D is dedicated to providing hospitals and medical device manufacturers with an innovative, user-friendly, and scalable solution for transforming DICOM medical images into actionable 3D data. Our advanced 510(k) cleared, AI-driven, cloud-based segmentation platform the heart of our technology—automating the conversion of patients' DICOM data into precise 3D visualizations, printable mesh files, and 3D models using Stratasys printing technology. The investment will be instrumental in further developing our platform, allowing us to expand our services and enhance our capabilities. With these additional resources, we aim to accelerate the accessibility of patient-specific 3D solutions, empowering surgeons, radiologists, and engineers to refine their practices and improve patient outcomes. This funding not only reflects investors' confidence in our vision and the effectiveness of our solutions but also supports our commitment to democratizing advanced medical technology worldwide. We are eager to leverage this funding to continue driving innovations that will bring tailor-made solutions to the forefront of medical procedures, ultimately enhancing the quality of care patients receive. Thank you to all of our investors, partners, and team members for believing in Axial3D’s vision and helping us make personalized medicine a reality for everyone.








